Use access key #2 to skip to page content.
$1.65 0.00 (0.00%)
8/20/2008 3:59 PM

Sunesis Pharmaceuticals, Inc. (SNSS)

CAPS Rating:
No stars

The Company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other unmet medical needs.

View All Commentary (SNSS)

Recs

0

Avatar theminc (< 20) Submitted: 10/06/06 9:28 PM : Underperform Start Price: $5.00 SNSS Score: 61.77

Early in the IPO. Solid company with a lot of bright minds. Results of clinical trial results will determine level of success.

Report this Post Replies: 0 | Reply

Featured Broker Partners